You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable

Article metrics

Article menu

Download PDFPDF

XML
Research Article
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable

 

Online download statistics by month:

Online download statistics by month: December 2019 to March 2024

AbstractFullPdf
Dec 2019330
Jan 202013131
Feb 2020444411
Mar 202044448
Apr 2020515110
May 2020636316
Jun 2020848416
Jul 202044449
Aug 2020494925
Sep 202012212237
Oct 2020676737
Nov 2020595923
Dec 2020585832
Jan 20219910062
Feb 2021747433
Mar 202110810851
Apr 2021646436
May 202112812854
Jun 2021646322
Jul 202110810842
Aug 2021555533
Sep 202110210235
Oct 20219810062
Nov 2021858557
Dec 2021939326
Jan 2022788536
Feb 20229310234
Mar 202229029965
Apr 2022868735
May 202212012755
Jun 2022819338
Jul 202210311038
Aug 2022495219
Sep 2022808321
Oct 2022727426
Nov 2022737728
Dec 2022767721
Jan 2023727220
Feb 2023535314
Mar 202310210322
Apr 2023727326
May 2023646529
Jun 2023909032
Jul 2023666840
Aug 2023626220
Sep 2023909015
Oct 202319819931
Nov 202328628819
Dec 202325526029
Jan 2024919130
Feb 2024686928
Mar 2024868741
Total463547171550